TickerGuard
Buy Day today: Poor (44) Weak market breadth · no major macro event
ACIU

AC Immune Ltd

Healthcare · Biotechnology

2.10$ -5.3% vs. previous close Closing price · As of: Nov 12, 2026

Statements

Balance Sheet

AC Immune Ltd (ACIU) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q3 26), "Total Assets" came in at 139 million CHF. Tick rows to compare them in a chart.

All figures in millions of CHF.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ACIU
Line item Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26
183 167 238 244 231 211 190 172 154 137 150 139
125 110 181 188 172 152 132 114 97 80 93 83
78 57 52 32 36 20 26 28 27 19 28 19
103 105 175 158 165 146 127 108 92 75 75 19
15 0.3 0.4 25 1.1 0.9 0.5 0.4 1.0 0.2 14 4.1
-0.6 -0.9 – – – – – – – – – –
– – – – – – – – – 50 – –
50 50 50 50 50 50 50 50 50 – 50 50
22 23 114 114 119 116 115 109 109 106 115 112
14 14 101 101 101 99 99 98 95 92 100 98
0.7 0.7 0.7 0.7 1.0 1.0 1.0 1.0 0.9 0.8 0.8 0.8
1.7 2.8 1.4 1.4 2.7 2.4 2.7 1.6 2.1 1.3 1.5 0.8
161 145 123 130 112 95 75 62 45 32 35 27
-316 -333 -355 -349 -368 -386 -407 -420 -440 -453 -450 -459
84 99 100 101 101 100 101 99 101 99 99 99

Data as of: November 12, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?